The Traderszone Network

Published in TZ Latest News 29 April, 2015 by The TZ Newswire Staff

What’s Behind Vertex Pharmaceuticals Incorporated’s Disappointing Q1

Another earnings miss from Vertex — but strong growth for cystic fibrosis drug Kalydeco.